####

### BY-COVID WP5 T5.2 Baseline Use Case

⬇️🏷️ Download all the metadata for BY-COVID WP5 T5.2 Baseline Use Case in JSON-LD format

### ⬇️📦 Download this dataset: BY-COVID WP5 T5.2 Baseline Use Case
BY-COVID WP5 T5.2 Baseline Use Case

@id | ./
name [?] | BY-COVID WP5 T5.2 Baseline Use Case
@type | Dataset
description [?] | This publication corresponds to the Research Objects (RO) of the Baseline Use Case proposed in T.5.2 (WP5) in the BY-COVID project on “COVID-19 Vaccine(s) effectiveness in preventing SARS-CoV-2 infection”.
funder [?] | European Commission
datePublished [?] | 2023-04-19
author [?] | Francisco Estupiñán-Romero Nina Van Goethem Marjan Meurisse Javier González-Galindo Enrique Bernal-Delgado
conformsTo [?] | Process Run Crate
codeRepository [?] | https://github.com/by-covid/BY-COVID_WP5_T5.2_baseline-use-case
hasPart [?] | BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Analytical pipeline BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Causal Model COVID-19 vaccine(s) effectiveness assessment (synthetic dataset) BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Data Management Plan BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Study protocol Common data model specification README.md
distribution [?] | https://github.com/by-covid/BY-COVID_WP5_T5.2_baseline-use-case/archive/refs/heads/main.zip
identifier [?] | https://doi.org/10.5281/zenodo.6913045
cite-as [?] | https://w3id.org/ro/doi/10.5281/zenodo.6913045
isBasedOn [?] | https://github.com/by-covid/BY-COVID_WP5_T5.2_baseline-use-case/releases/tag/1.0.1 https://doi.org/10.5281/zenodo.6913045 https://doi.org/10.5281/zenodo.7551181 https://doi.org/10.5281/zenodo.7625783
keywords [?] | COVID-19, vaccines, comparative effectiveness, causal inference, international comparison, SARS-CoV-2, common data model, directed acyclic graph, synthetic data
license [?] | Creative Commons Attribution 4.0 International
dateModified [?] | 2023-10-05
publisher [?] | BY-COVID
funding [?] | HORIZON-INFRA-2021-EMERGENCY-01 101046203
mentions [?] | Generating HTML from QMD Execution of pandas-profiling for exploratory data analysis dataspice JSON-LD created from CSV templates Second (?) execution of Jupyter Notebook to generate 650k synthetic dataset Execution of Jupyter Notebook to generate 10k synthetic dataset RO-Crate metadata created based on README and dataspice JSON-LD
url [?] | https://by-covid.github.io/BY-COVID_WP5_T5.2_baseline-use-case/
version [?] | 1.2.0
assesses [?] | Research Question: How effective have the SARS-CoV-2 vaccination programmes been in preventing SARS-CoV-2 infections?
material [?] | Cohort definition: All individuals (from 5 to 115 years old, included) vaccinated with at least one dose of the SARS-CoV-2 vaccine (any of the available brands) and all individuals eligible to be vaccinated with a documented positive diagnosis (irrespective of the type of test) for a SARS-CoV-2 infection during the data extraction period.
materialExtent [?] | Inclusion criteria: All people vaccinated with at least one dose of the COVID-19 vaccine (any of the available brands) in an area of residence. Any person eligible to be vaccinated (from 5 to 115 years old, included) with a positive diagnosis (irrespective of the type of test) for SARS-CoV-2 infection (COVID-19) during the period of data extraction. Exclusion criteria: People not eligible for the vaccine (from 0 to 4 years old, included)
publishingPrinciples [?] | Study Design: An observational retrospective longitudinal study to assess the effectiveness of the SARS-CoV-2 vaccines in preventing SARS-CoV-2 infections using routinely collected social, health and care data from several countries. A causal model was established using Directed Acyclic Graphs (DAGs) to map domain knowledge, theories and assumptions about the causal relationship between exposure and outcome.
temporalCoverage [?] | Study Period: From the date of the first documented SARS-CoV-2 infection in each country to the most recent date in which data is available at the time of analysis. Roughly from 01-03-2020 to 30-06-2022, depending on the country.
usageInfo [?] | The scripts (software) included in the publication are offered "as-is", without warranty, and disclaiming liability for damages resulting from using it. The software is released under the CC-BY-4.0 licence, which gives you permission to use the content for almost any purpose (but does not grant you any trademark permissions), so long as you note the license and give credit.
releaseNotes [?] | - Updated Causal model to eliminate the consideration of 'vaccination_schedule_cd' as a mediator - Adjusted the study period to be consistent with the Study Protocol - Updated 'sex_cd' as a required variable - Added 'chronic_liver_disease_bl' as a comorbidity at the individual level - Updated 'socecon_lvl_cd' at the area level as a recommended variable -Added crosswalks for the definition of 'chronic_liver_disease_bl' in a separate sheet -Updated the 'vaccination_schedule_cd' reference to the 'Vaccine' node in the updated DAG -Updated the description of the 'confirmed_case_dt' and 'previous_infection_dt' variables to clarify the definition and the need for a single registry per person
Items that reference this one
about [?] | ro-crate-metadata.json README.md

### Go to: European Commission

@id | https://ror.org/00k4n6c32
name [?] | European Commission
@type | Organization
Items that reference this one
funder [?] | BY-COVID WP5 T5.2 Baseline Use Case HORIZON-INFRA-2021-EMERGENCY-01 101046203

### Go to: Francisco Estupiñán-Romero

@id | https://orcid.org/0000-0002-6285-8120
name [?] | Francisco Estupiñán-Romero
@type | Person
affiliation [?] | Instute for Health Science in Aragon (IACS)
email [?] | festupinnan.iacs@aragon.es
Items that reference this one
author [?] | BY-COVID WP5 T5.2 Baseline Use Case BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Analytical pipeline
creator [?] | BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Data Management Plan BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Study protocol BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Causal Model COVID-19 vaccine(s) effectiveness assessment (synthetic dataset)

### Go to: Nina Van Goethem

@id | https://orcid.org/0000-0001-7316-6990
name [?] | Nina Van Goethem
@type | Person
affiliation [?] | Sciensano
email [?] | Nina.VanGoethem@sciensano.be
Items that reference this one
author [?] | BY-COVID WP5 T5.2 Baseline Use Case README.md BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Analytical pipeline
creator [?] | BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Data Management Plan BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Study protocol BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Causal Model COVID-19 vaccine(s) effectiveness assessment (synthetic dataset)

### Go to: Marjan Meurisse

@id | https://orcid.org/0000-0002-4409-0664
name [?] | Marjan Meurisse
@type | Person
affiliation [?] | Sciensano
email [?] | Marjan.Meurisse@sciensano.be
Items that reference this one
author [?] | BY-COVID WP5 T5.2 Baseline Use Case README.md BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Analytical pipeline
creator [?] | BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Data Management Plan BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Study protocol BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Causal Model COVID-19 vaccine(s) effectiveness assessment (synthetic dataset)

### Go to: Javier González-Galindo

@id | https://orcid.org/0000-0002-8783-5478
name [?] | Javier González-Galindo
@type | Person
affiliation [?] | Instute for Health Science in Aragon (IACS)
email [?] | jgonzalezga.iacs@aragon.es
Items that reference this one
author [?] | BY-COVID WP5 T5.2 Baseline Use Case BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Analytical pipeline
creator [?] | BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Study protocol BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Causal Model COVID-19 vaccine(s) effectiveness assessment (synthetic dataset)

### Go to: Enrique Bernal-Delgado

@id | https://orcid.org/0000-0002-0961-3298
name [?] | Enrique Bernal-Delgado
@type | Person
affiliation [?] | Instute for Health Science in Aragon (IACS)
email [?] | ebernal.iacs@aragon.es
Items that reference this one
author [?] | BY-COVID WP5 T5.2 Baseline Use Case BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Analytical pipeline
creator [?] | BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Data Management Plan BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Study protocol BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Causal Model COVID-19 vaccine(s) effectiveness assessment (synthetic dataset)

### Go to: Process Run Crate

@id | https://w3id.org/ro/wfrun/process/0.1
name [?] | Process Run Crate
@type | CreativeWork
version [?] | 0.1
Items that reference this one
conformsTo [?] | BY-COVID WP5 T5.2 Baseline Use Case

### BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Analytical pipeline

@id | vaccine_effectiveness_analytical_pipeline/
name [?] | BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Analytical pipeline
@type | Dataset
description [?] | Reproducable analytical pipeline to apply causal inference techniques using distributed observational data
datePublished [?] | 2023-04-26
author [?] | Francisco Estupiñán-Romero Nina Van Goethem Marjan Meurisse Javier González-Galindo Enrique Bernal-Delgado
version [?] | 1.0.0
url [?] | https://github.com/by-covid/BY-COVID_WP5_T5.2_baseline-use-case/tree/main/vaccine_effectiveness_analytical_pipeline
hasPart [?] | vaccine_effectiveness_analytical_pipeline/docker/ Documentation analytical pipeline (PDF) Synthetic dataset with 10k entries (CSV) Output analytical pipeline Scripts analytical pipeline Dockerfile Analytical pipeline R project file (RPROJ) .yml file listing dependencies (YML) Installation required R packages (R)
Items that reference this one
hasPart [?] | BY-COVID WP5 T5.2 Baseline Use Case

### ⬇️ Download: BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Causal Model

@id | vaccine_effectiveness_causal_model/
name [?] | BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Causal Model
@type | File
description [?] | Causal model responding to the research question, using a Directed Acyclic Graph
datePublished [?] | 2023-01-26
version [?] | 1.1.0
identifier [?] | https://doi.org/10.5281/zenodo.6913045
url [?] | https://zenodo.org/record/7572373
creator [?] | Francisco Estupiñán-Romero Nina Van Goethem Marjan Meurisse Javier González-Galindo Enrique Bernal-Delgado
contributor [?] | Simon Saldner Lorenz Dolanski-Aghamanoukjan Alexander Degelsegger-Marquez Martínez-Lizaga, Natalia
hasPart [?] | COVID-19 vaccine effectiveness causal model v.1.1.0 (HTML) COVID-19 vaccine effectiveness causal model v.1.1.0 (QMD)
Items that reference this one
hasPart [?] | BY-COVID WP5 T5.2 Baseline Use Case BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Data Management Plan BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Study protocol

### COVID-19 vaccine(s) effectiveness assessment (synthetic dataset)

@id | vaccine_effectiveness_common_data_model_specification/
name [?] | COVID-19 vaccine(s) effectiveness assessment (synthetic dataset)
@type | Dataset
description [?] | Synthetic data set to test the causal model proposed by the baseline use case in BY-COVID WP5 assessing the effectiveness of the COVID-19 vaccine(s)
datePublished [?] | 2023-01-26
version [?] | 1.1.0
identifier [?] | https://doi.org/10.5281/zenodo.6913045
url [?] | https://zenodo.org/record/7572373
creator [?] | Francisco Estupiñán-Romero Nina Van Goethem Marjan Meurisse Javier González-Galindo Enrique Bernal-Delgado
contributor [?] | Simon Saldner Lorenz Dolanski-Aghamanoukjan Alexander Degelsegger-Marquez Martínez-Lizaga, Natalia
distribution [?] | vaccine_effectiveness_synthetic_pop_10k_v.1.1.0
hasPart [?] | vaccine_effectiveness_synthetic_pop_10k_v.1.1.0 Metadata for Common data model specification Documentation for Common data model specification vaccine effectiveness data model specification (XLXS)
keywords [?] | synthetic data dataset covid-19 vaccines effectiveness causal model
license [?] | Creative Commons Attribution 4.0 International
spatialCoverage [?] | Europe
subjectOf [?] | Metadata for Common data model specification
temporalCoverage [?] | 01-01-2020/31-12-2024
variableMeasured [?] | person_id: undefined age_nm: undefined sex_cd: undefined socecon_lvl_cd: undefined residence_area_cd: undefined country_cd: undefined foreign_bl: undefined exitus_dt: undefined exitus_bl: undefined essential_worker_bl: undefined institutionalized_bl: undefined dose_1_brand_cd: undefined dose_1_dt: undefined dose_2_brand_cd: undefined dose_2_dt: undefined dose_3_brand_cd: undefined dose_3_dt: undefined number_doses: undefined fully_vaccinated_dt: undefined fully_vaccinated_bl: undefined vaccination_schedule_cd: undefined confirmed_case_dt: undefined confirmed_case_bl: undefined previous_infection_dt: undefined previous_infection_bl: undefined test_type_cd: undefined variant_cd: undefined diabetes_bl: undefined obesity_bl: undefined heart_failure_bl: undefined copd_bl: undefined solid_tumor_without_metastasis_bl: undefined chronic_kidney_disease_bl: undefined sickle_cell_disease_bl: undefined hypertension_bl: undefined blood_cancer_bl: undefined transplanted_bl: undefined hiv_infection_bl: undefined primary_immunodeficiency_bl: undefined immunosuppression_bl: undefined pregnancy_bl: undefined
Items that reference this one
hasPart [?] | BY-COVID WP5 T5.2 Baseline Use Case BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Data Management Plan BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Study protocol
about [?] | Metadata for Common data model specification Documentation for Common data model specification COVID-19 vaccine effectiveness data model specification dataspice (HTML)
mainEntity [?] | COVID-19 vaccine effectiveness data model specification dataspice (JSON)

### BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Data Management Plan

@id | vaccine_effectiveness_data_management_plan/
name [?] | BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Data Management Plan
@type | Dataset
description [?] | Data management plan
datePublished [?] | 2023-02-09
version [?] | 0.0.1
identifier [?] | https://doi.org/10.5281/zenodo.7625783
url [?] | https://zenodo.org/record/7625784
creator [?] | Martínez-Lizaga, Natalia Marjan Meurisse Francisco Estupiñán-Romero Nina Van Goethem Enrique Bernal-Delgado
hasPart [?] | Data management plan v.0.0.1 (JSON) Data management plan v.0.0.1 (PDF) Common data model specification BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Causal Model COVID-19 vaccine(s) effectiveness assessment (synthetic dataset) BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Study protocol
Items that reference this one
hasPart [?] | BY-COVID WP5 T5.2 Baseline Use Case

### BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Study protocol

@id | vaccine_effectiveness_study_protocol/
name [?] | BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Study protocol
@type | Dataset
description [?] | Study protocol
datePublished [?] | 2023-04-13
version [?] | 1.0.3
identifier [?] | https://doi.org/10.5281/zenodo.7551181
url [?] | https://zenodo.org/record/7825979
creator [?] | Marjan Meurisse Nina Van Goethem Francisco Estupiñán-Romero Javier González-Galindo https://orcid.org/0000-0002-0048-4370 Martínez-Lizaga, Natalia Enrique Bernal-Delgado
hasPart [?] | Study protocol v.1.0.3 (PDF) Common data model specification BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Causal Model COVID-19 vaccine(s) effectiveness assessment (synthetic dataset)
Items that reference this one
hasPart [?] | BY-COVID WP5 T5.2 Baseline Use Case BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Data Management Plan

### Common data model specification

@id | vaccine_effectiveness_synthetic_dataset/
name [?] | Common data model specification
@type | Dataset
description [?] | following the causal model
datePublished [?] | 2023-01-26
version [?] | 1.1.0
identifier [?] | https://doi.org/10.5281/zenodo.6913045
url [?] | https://zenodo.org/record/7572373
hasPart [?] | COVID-19 vaccine effectiveness synthetic dataset generation script (IPYNB) COVID-19 vaccine effectiveness synthetic dataset EDA (HTML) COVID-19 vaccine effectiveness synthetic dataset EDA (JSON) Synthetic dataset with 650k entries
Items that reference this one
hasPart [?] | BY-COVID WP5 T5.2 Baseline Use Case BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Data Management Plan BY-COVID - WP5 - Baseline Use Case: SARS-CoV-2 vaccine effectiveness assessment - Study protocol

### ⬇️ Download: README.md

@id | README.md
@type | File
author [?] | Nina Van Goethem Marjan Meurisse
encodingFormat [?] | text/markdown
about [?] | BY-COVID WP5 T5.2 Baseline Use Case
Items that reference this one
hasPart [?] | BY-COVID WP5 T5.2 Baseline Use Case
object [?] | RO-Crate metadata created based on README and dataspice JSON-LD

### Go to: https://github.com/by-covid/BY-COVID_WP5_T5.2_baseline-use-case/archive/refs/heads/main.zip

@id | https://github.com/by-covid/BY-COVID_WP5_T5.2_baseline-use-case/archive/refs/heads/main.zip
@type | DataDownload
encodingFormat [?] | application/zip
contentSize [?] | 10978259
contentUrl [?] | https://github.com/by-covid/BY-COVID_WP5_T5.2_baseline-use-case/archive/refs/heads/main.zip
Items that reference this one
distribution [?] | BY-COVID WP5 T5.2 Baseline Use Case

### Go to: Creative Commons Attribution 4.0 International

@id | https://spdx.org/licenses/CC-BY-4.0
name [?] | Creative Commons Attribution 4.0 International
@type | Thing
identifier [?] | CC-BY-4.0
url [?] | https://creativecommons.org/licenses/by/4.0/
Items that reference this one
license [?] | BY-COVID WP5 T5.2 Baseline Use Case COVID-19 vaccine(s) effectiveness assessment (synthetic dataset)

### Go to: BY-COVID

@id | https://by-covid.eu/
name [?] | BY-COVID
@type | Project
description [?] | BeYond-COVID, make data from COVID-19 and other infectious diseases open and accessible to everyone
url [?] | https://by-covid.eu/
funding [?] | HORIZON-INFRA-2021-EMERGENCY-01 101046203
Items that reference this one
publisher [?] | BY-COVID WP5 T5.2 Baseline Use Case

### Go to: HORIZON-INFRA-2021-EMERGENCY-01 101046203

@id | https://doi.org/10.3030/101046203
name [?] | HORIZON-INFRA-2021-EMERGENCY-01 101046203
@type | Grant
funder [?] | European Commission
identifier [?] | https://doi.org/10.3030/101046203
Items that reference this one
funding [?] | BY-COVID WP5 T5.2 Baseline Use Case BY-COVID

### Generating HTML from QMD

@id | #qmd-generation
name [?] | Generating HTML from QMD
@type | CreateAction
endTime [?] | 2022-07-27T12:00:00+01:00
instrument [?] | Quarto
object [?] | COVID-19 vaccine effectiveness causal model v.1.1.0 (QMD)
result [?] | COVID-19 vaccine effectiveness causal model v.1.1.0 (HTML)
Items that reference this one
mentions [?] | BY-COVID WP5 T5.2 Baseline Use Case

### Execution of pandas-profiling for exploratory data analysis

@id | #panda-analysis
name [?] | Execution of pandas-profiling for exploratory data analysis
@type | CreateAction
endTime [?] | 2022-05-27T09:52:32.926250
instrument [?] | pandas-profiling v3.1.0
object [?] | Synthetic dataset with 650k entries pandas-profiling config
result [?] | COVID-19 vaccine effectiveness synthetic dataset EDA (JSON) COVID-19 vaccine effectiveness synthetic dataset EDA (HTML)
startTime [?] | 2022-05-27T09:52:29.847284
Items that reference this one
mentions [?] | BY-COVID WP5 T5.2 Baseline Use Case

### dataspice JSON-LD created from CSV templates

@id | #dataspice-creation
name [?] | dataspice JSON-LD created from CSV templates
@type | CreateAction
endTime [?] | 2022-07-27
instrument [?] | dataspice
object [?] | vaccine_effectiveness_common_data_model_specification/data/metadata/access.csv vaccine_effectiveness_common_data_model_specification/data/metadata/attributes.csv vaccine_effectiveness_common_data_model_specification/data/metadata/biblio.csv vaccine_effectiveness_common_data_model_specification/data/metadata/creators.csv vaccine_effectiveness_synthetic_pop_10k_v.1.1.0
result [?] | COVID-19 vaccine effectiveness data model specification dataspice (JSON) COVID-19 vaccine effectiveness data model specification dataspice (HTML)
Items that reference this one
mentions [?] | BY-COVID WP5 T5.2 Baseline Use Case

### Second (?) execution of Jupyter Notebook to generate 650k synthetic dataset

@id | #notebook-execution-650k
name [?] | Second (?) execution of Jupyter Notebook to generate 650k synthetic dataset
@type | CreateAction
description [?] | Note that this CSV has only 650k entries, but the Notebook code is meant to crate 1M entries. A modified notebook must have been executed.
endTime [?] | 2022-05-24
instrument [?] | COVID-19 vaccine effectiveness synthetic dataset generation script (IPYNB)
result [?] | Synthetic dataset with 650k entries
Items that reference this one
mentions [?] | BY-COVID WP5 T5.2 Baseline Use Case

### Execution of Jupyter Notebook to generate 10k synthetic dataset

@id | #notebook-execution-1M
name [?] | Execution of Jupyter Notebook to generate 10k synthetic dataset
@type | CreateAction
endTime [?] | 2022-05-24
instrument [?] | COVID-19 vaccine effectiveness synthetic dataset generation script (IPYNB)
result [?] | vaccine_effectiveness_synthetic_dataset/vaccines_effectiveness_synthetic_pop_10k_v.1.1.0.csv
Items that reference this one
mentions [?] | BY-COVID WP5 T5.2 Baseline Use Case

### RO-Crate metadata created based on README and dataspice JSON-LD

@id | #metadata-creation
name [?] | RO-Crate metadata created based on README and dataspice JSON-LD
@type | CreateAction
actionStatus [?] | http://schema.org/CompletedActionStatus
agent [?] | Stian Soiland-Reyes
endTime [?] | 2023-01-06
object [?] | COVID-19 vaccine effectiveness data model specification dataspice (JSON) README.md
result [?] | ro-crate-metadata.json
Items that reference this one
mentions [?] | BY-COVID WP5 T5.2 Baseline Use Case